ABSTRACT
INTRODUCTION
Several well-established factors have been associated with the prognosis of breast cancer such as size of tumour, lymph node involvement, histological type, oestrogen and progesterone receptor status, and so on. With modern medical model transforming from biomedical model to biology-psychology-community medical model, the therapy no longer simply emphasize elimination of tumor and prolongation of life span, at the same time, the improvement of the quality of life is emphasized as well [1] . Owing to the fact that success of treatment in prolonging life is a mixed blessing-it is not enough to survive, patients also want to live [2] . Quality of life (QoL) is currently an important factor in oncological research [3] . QoL and its components and determinants have received growing interest [4] [5] [6] [7] [8] , and physical, mental and social well-being, with varying levels of emphasis and in various combinations, have been included in the concept [2, 4, 9, 10] . As a whole, women who remain free of breast cancer seem to have levels of functioning and QoL that are comparable to those of the general female population, although those who receive systemic adjuvant chemotherapy may do less well [11] . As a result, study for patients' QoL is being emphasized. At the same time, we also hypothesized that women with greater social-emotional support would also survive longer when compared with women with less or no support. Therefore, we explored other potential barriers to patients. By assessing its associations with demographic and clinical characteristics and social support (given retrospective evidence of its positive relationship with participation). The aim of our study was to evaluate clinical characteristics, social support and the association with the prognosis of breast cancer patients. Our study pulled 21 factors about clinical pathology and lifestyle into Cox model which may influence postoperative patients with breast cancer to make clinical synthetic evaluation and analysis in order to improve their QoL and get long-term survival.
METHODS

Participants
Women aged 23-82 years, diagnosed with a first pathol- 
Data Collection
On the basis of all sources of information, we reconstructed a detailed medical history for each patient. In compiling all sources of information, we also ascertained breast cancer stage, histology, estrogen receptor (ER) status, methods of treatment, age at diagnosis, gestagenic history, and married status [12] through their abstraction of pathology reports and medical records relating to breast cancer diagnosis. For women who had two or more primary cancers diagnosed within the follow-up time, we took the earliest diagnosis, or if both tumors were diagnosed on the same date, the tumor characteristics are those associated with the larger tumor.
Although we were able to confirm most exposure histories of patients through interview of medical records, we were unable to confirm other information. Thus, the exposure information, such as educational level, occupation, emotional function, social function and economical status correlated with health, were obtained by trained interviewers that asked patients, their husband or firstdegree relatives. All data were collected with a standardized questionnaire using a telephone interview. Variables included demographics, emotional function, social function and economical status. If patients die, interviewers must obtain their age at death. Due to the nature of the data collected (medical records and telephone interview), complete information was impossible for some of the variable assessed. In some instances (e.g. the history of other chronic disease, emotional function, social function and economical status) over 35% of the data were missing, therefore these variables were excluded from the analysis. In the end, complete information was available for 204 cases from the initial study population of 300 cases.
Statistical Methods
Twenty-one features of patients, clinical pathologic factors and lifestyle have been selected as the indexes of analysis and been quantified, which came from clinical records and may influence prognosis of patients with breast cancer. Patients' live time were calculated by month, which means the time span from the operation day to death or termination of follow-up visit, and we put corresponding data of every patient into computer on the basis of clinical records and results of follow-up visit, and data was dealt by SAS9.0 for WINDOWS software and the survival rate was calculated by life table method. All indexes of survival rate difference were analyzed by multiple factor Cox proportional hazard model (using gradually backward progressive method, two-tailed α = 0.05).
RESULTS
The 17 categorical variables were summarized in Table  1 . For the model selection there were records with missing variables. Previous analysis on these datasets suggested that missing variables might be informative. Therefore, any missing values in the 17 categories were coded as a separate attribute.
The distributions of various demographic, reproductive and medical characteristics of the cohort were provided in Table 2 . Among the 204 women included in this analysis, 48.04% had at least a college degree, 13.24% had a first-degree family history of breast cancer and 83.33% had biopsy for benign breast cancer. The majority was later-stage cancers, and 190 (93.14%) had infiltrating type.
Multivariate Cox proportional hazard model analysis was showed in Table 3 . On the level of α = 0. 05, it was indicated by analytic results that outstanding factors including age at diagnosis, T staging, N staging, emotional function, the level of the hospital, may influence survival time statistically. Age at diagnosis was protective factors (coefficient of regression was negative), the rest were all risk factor (coefficient of regression was upright).
Survival analysis of clinical stage nodes was showed in Figure 1 . Two survival graphs of nodes found negative by histology and nodes found positive by histology were analyzed by log-rank test, there was statistically significant relationship between two survival graphs (x 2 = 136.8467, p < 0.0001).
DISCUSSION
Age at diagnosis is one of the most definitive risk factors on breast cancer. Sixty-five percent of all breast cancers occur in women aged 55 and older. Our study found that age at diagnosis was one of prognostic factors. The younger patients at diagnosis showed lower death hazard (Hazard Ratio: 0.972). But none of the prior studies showed that age was one of the prognostic factors, and it is difficult to hypothesize why age at diagnoses would be more closely related to survival time. We presume that the younger patients at diagnose may have fewer hance of developing other chronic diseases and be more c healthy than elder patients so that they can survive longer. Further studies are needed to confirm these findings, given that this is the first study to report these associations of breast cancer patients. Tumor size and clinical stage nodes are two of the most important prognostic factors, although tumor grade may modify this risk assessment. Most commonly used indexes of clinic to evaluate its prognosis referred to TMN staging system and degree of tumor pathology [13] , which reflects pathological anatomic scope and histological transformation affecting prognosis. In general, women who have a tumor that measures less than 1 cm with negative axillary lymph nodes have a greater than 95% chance of a 10-year disease-free survival. As the tumor size approaches 2 cm, the chance of being disease free within 10 years drops to about 70% [13] . Previous studies had indicated the relationship between clinical stage tumor, clinical stage nodes and prognosis. Our study also found that HR of T4 was 2.075-fold higher than T1 and Hazard Ratio of N3 was 1.513-fold higher than N0. Moreover, we analyzed two survival graph in different clinical stage nodes because clinical stage nodes as Variable was entered firstly into Cox proportional hazard model, and the analysis result of log-rank test of survival graph showed that there was statistically significant relationship between two survival graphs (x 2 = 136.8467, p < 0.0001). Thus, we conclude that clinical stage tumor and clinical stage nodes are two of the most important prognostic factors and the patients of nodes removed indicated lower survival than no nodes found clinically or node negative by histology.
In summary, our results suggest that age at diagnoses, Clinical stage tumor and node could contribute to the development of breast cancer and disease free survival in Chinese women.
LIMITATIONS
After interpreting the results of this study, it is important to acknowledge its limitations. A limitation of this study was the small, cross-sectional sample related to reported frequencies of symptoms, yet the size of the sample is consistent with qualitative inquiry. Another limitation is participants' recall of their symptoms and information and support needs during the 5 years following therapy. The primary exposures of interest include early-life events, and given that some women in participants are older than 50 years, recall of exact events may have been poor for some women resulting in exposure misclassification. The resultant bias would be non-differential, given that a cohort design was used and, thus would lead to underestimations of the true relative risks. Finally, we were only able to include 68% of the potentially eligible women in this study because 32% confounder data were missing. Given the prospective nature of this study these exclusions are unlikely to bias our results. Some variables, such as Hormonal dependent (ER, PR detection result), Family history of breast cancer in first-degree relative, Menopausal status are not internalized into the COX function, but they could be further researched on the basis of expanded sample in future.
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